510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2233-2014Class III

BD Multi Check CD4 Low Control Catalog No. 340916 is intended as a complete process control for...

Becton, Dickinson and Company, BD Biosciences / initiated 2014-07-18 / Terminated / root cause: labeling and UDI

BD Biosciences, Systems & Reagents began a recall of BD Multi Check CD4 Low Control Catalog No. 340916 is intended as a complete process control for immunophenotyping by flow cytometry on . FDA classified it as Class III and gives the reason as "The outer box label contains the incorrect distribution date: Box states ; should be ". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2233-2014
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton, Dickinson and Company, BD Biosciences
Product
BD Multi Check CD4 Low Control Catalog No. 340916 is intended as a complete process control for immunophenotyping by flow cytometry.
Product code
GKZ Counter, Differential Cell
Reason for recall
The outer box label contains the incorrect distribution date: Box states 2017-09-02 ; should be 2014-09-02
Root cause tag
labeling and UDI
FDA root cause
Labeling mix-ups
Action
Global hold initiated on July 18, 2014. Customer letters sent by certified mail on July 18, 2014 to advised users of the problem.
Quantity in commerce
85
Distribution
IN, MA, TX, VA, Ca, KY, MD, PA, GA, and BD locations in Singapore and Belgium
Product codes and lots
Catalog number 340916; Lot number BM084L

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2233-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2233-2014Class IIITerminatedVoluntary: Firm initiated